[Melatonin Inhibits Growth and Metastasis of MDA-MB-231 Breast Cancer Cells by Activating Autophagy]

Overview

Journal Nan Fang Yi Ke Da Xue Xue Bao

Specialty General Medicine

Date 2022 Apr 2

PMID 35365454

Authors

D Wu

Y Zhang

H Tang

J Yang

M Li

H Liu

Q Li

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the effects of melatonin on the growth and metastasis of MDA-MB-231 breast cancer cells and explore the mechanism.

Methods: MDA-MB-231 cells were treated with 1, 3 or 5 mmol/L melatonin, and the changes in cell proliferation were examined using CCK-8 assay. Colony-forming assay and wound healing assay were used to assess the effects of melatonin treatmnent on colony-forming ability and migration of the cells. Flow cytometry and immunofluoresnce assay were employed to examine apoptosis and positive staining for autophagy-related proteins in the cells treated with 3 mmol/L melatonin. The effects of melatonin treatment alone or in combination with 3-methyladenine (3-MA) on the expressions of the proteins associated with autophagy (LC3, P62 and Beclin1), apoptosis (Bcl2 and Bax) and epithelial-mesenchymal transition (E-cadherin and Snail) were examined with Western blotting.

Results: Melatonin treatment significantly inhibited the proliferation of breast cancer cells in a concentration- and time-dependent manner ( < 0.05), suppressed colony-forming ability and migration ( < 0.01), and promoted apoptosis of the cells ( < 0.01). Melatonin treatment alone significantly increased the expressions of Bax ( < 0.05), E-cadherin, LC3-II/LC3-I, and Beclin1 and lowered the expressions of Bcl2 ( < 0.05), Snail, P62 ( < 0.05), and Bcl2/Bax ratio ( < 0.01) in the cells, and caused enhanced positive staining of Beclin1 protein and attenuated staining of P62 protein. Compared with melatonin treatment alone, melatonin treatment combined with 3-MA significantly decreased the expressions of Beclin1 ( < 0.001), LC3-II/LC3-I ( < 0.05), Bax ( < 0.01), and E-cadherin ( < 0.001) and increased the expressions of Bcl2 ( < 0.05), Snail, and Bcl2/Bax ratio ( < 0.01).

Conclusion: Melatonin can induce autophagy of MDA-MB-231 breast cancer cells to inhibit cell proliferation and metastasis and promote cell apoptosis, and suppressing autophagy can weaken the inhibitory effect of melatonin on the growth and metastasis of breast cancer cells.

Citing Articles

Melatonin Regulates the Daily Levels of Plasma Amino Acids, Acylcarnitines, Biogenic Amines, Sphingomyelins, and Hexoses in a Xenograft Model of Triple Negative Breast Cancer.

Junior R, de Almeida Chuffa L, Simao V, Sonehara N, Chammas R, Reiter R Int J Mol Sci. 2022; 23(16).

PMID: 36012374 PMC: 9408859. DOI: 10.3390/ijms23169105.

References

Katheder N, Khezri R, OFarrell F, Schultz S, Jain A, Rahman M . Microenvironmental autophagy promotes tumour growth. Nature. 2017; 541(7637):417-420. PMC: 5612666. DOI: 10.1038/nature20815. View

Wu H, Liu J, Yin Y, Zhang D, Xia P, Zhu G . Therapeutic Opportunities in Colorectal Cancer: Focus on Melatonin Antioncogenic Action. Biomed Res Int. 2019; 2019:9740568. PMC: 6766109. DOI: 10.1155/2019/9740568. View

Kong X, Gao R, Wang Z, Wang X, Fang Y, Gao J . Melatonin: A Potential Therapeutic Option for Breast Cancer. Trends Endocrinol Metab. 2020; 31(11):859-871. DOI: 10.1016/j.tem.2020.08.001. View

Wang X, Wang Z, Cao J, Dong Y, Chen Y . Melatonin ameliorates anxiety-like behaviors induced by sleep deprivation in mice: Role of oxidative stress, neuroinflammation, autophagy and apoptosis. Brain Res Bull. 2021; 174:161-172. DOI: 10.1016/j.brainresbull.2021.06.010. View

Vimalraj S, Saravanan S, Raghunandhakumar S, Anuradha D . Melatonin regulates tumor angiogenesis via miR-424-5p/VEGFA signaling pathway in osteosarcoma. Life Sci. 2020; 256:118011. DOI: 10.1016/j.lfs.2020.118011. View

Nagaraja S, Subramanian U, Nagarajan D . Radiation-induced H3K9 methylation on E-cadherin promoter mediated by ROS/Snail axis : Role of G9a signaling during lung epithelial-mesenchymal transition. Toxicol In Vitro. 2020; 70:105037. DOI: 10.1016/j.tiv.2020.105037. View

Li Y, Ning N, Song L, Geng Y, Fan J, Ma C . Derivatives of Deoxypodophyllotoxin Induce Apoptosis through Bcl-2/Bax Proteins Expression. Anticancer Agents Med Chem. 2020; 21(5):611-620. DOI: 10.2174/1871520620999200730160952. View

Kubatka P, Zubor P, Busselberg D, Kwon T, Adamek M, Petrovic D . Melatonin and breast cancer: Evidences from preclinical and human studies. Crit Rev Oncol Hematol. 2018; 122:133-143. DOI: 10.1016/j.critrevonc.2017.12.018. View

Strasser A, Vaux D . Cell Death in the Origin and Treatment of Cancer. Mol Cell. 2020; 78(6):1045-1054. DOI: 10.1016/j.molcel.2020.05.014. View

10.

Huang Y, Yuan K, Tang M, Yue J, Bao L, Wu S . Melatonin inhibiting the survival of human gastric cancer cells under ER stress involving autophagy and Ras-Raf-MAPK signalling. J Cell Mol Med. 2020; 25(3):1480-1492. PMC: 7875909. DOI: 10.1111/jcmm.16237. View

11.

Russo M, Russo G . Autophagy inducers in cancer. Biochem Pharmacol. 2018; 153:51-61. DOI: 10.1016/j.bcp.2018.02.007. View

12.

Ganesh K, Massague J . Targeting metastatic cancer. Nat Med. 2021; 27(1):34-44. PMC: 7895475. DOI: 10.1038/s41591-020-01195-4. View

13.

Keyvanloo Shahrestanaki M, Bagheri M, Ghanadian M, Aghaei M, Jafari S . Centaurea cyanus extracted 13-O-acetylsolstitialin A decrease Bax/Bcl-2 ratio and expression of cyclin D1/Cdk-4 to induce apoptosis and cell cycle arrest in MCF-7 and MDA-MB-231 breast cancer cell lines. J Cell Biochem. 2019; 120(10):18309-18319. DOI: 10.1002/jcb.29141. View

14.

Hill S, Wrobel L, Ashkenazi A, Fernandez-Estevez M, Tan K, Burli R . VCP/p97 regulates Beclin-1-dependent autophagy initiation. Nat Chem Biol. 2021; 17(4):448-455. DOI: 10.1038/s41589-020-00726-x. View

15.

Rossi L, Mazzara C, Pagani O . Diagnosis and Treatment of Breast Cancer in Young Women. Curr Treat Options Oncol. 2019; 20(12):86. DOI: 10.1007/s11864-019-0685-7. View

16.

Liu R, Wang H, Deng M, Wen X, Mo Y, Chen F . Melatonin Inhibits Reactive Oxygen Species-Driven Proliferation, Epithelial-Mesenchymal Transition, and Vasculogenic Mimicry in Oral Cancer. Oxid Med Cell Longev. 2018; 2018:3510970. PMC: 5884151. DOI: 10.1155/2018/3510970. View

17.

Ao L, Li L, Sun H, Chen H, Li Y, Huang H . Transcriptomic analysis on the effects of melatonin in gastrointestinal carcinomas. BMC Gastroenterol. 2020; 20(1):233. PMC: 7372748. DOI: 10.1186/s12876-020-01383-z. View

18.

Zhang L, He Y, Wu X, Zhao G, Zhang K, Yang C . Melatonin and (-)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer. Cells. 2019; 8(7). PMC: 6678710. DOI: 10.3390/cells8070745. View

19.

Fernandez-Gil B, Guerra-Librero A, Shen Y, Florido J, Martinez-Ruiz L, Garcia-Lopez S . Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy. Oxid Med Cell Longev. 2019; 2019:7187128. PMC: 6421819. DOI: 10.1155/2019/7187128. View

20.

Xiao B, Dong L, Gao H, Yang K, Wang Y, Li X . [Effects of melatonin on PBDE-47-induced abnormal autophagy and apoptosis in PC12 cells]. Nan Fang Yi Ke Da Xue Xue Bao. 2021; 41(9):1409-1414. PMC: 8526320. DOI: 10.12122/j.issn.1673-4254.2021.09.17. View